CD44 and neoplasm: By regulating the expression level of CD44 or interfering with its downstream signaling pathways, scientists expect to develop effective strategies to inhibit tumor growth, which not only emphasizes the potential of CD44 as a therapeutic target, but also highlights its importance as a biomarker for predicting tumor prognosis.